11th annual ADMET conference and exhibition
13 – 14 June 2016
London, UK
Contact e-mail: zgale@smi-online.co.uk
Contact tel: +44 (0) 207 827 6093
www.admet-event.com/rsc
The SMi Group is proud to announce the return of the 11th annual ADMET conference taking place in London on the 13th – 14th June.
This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.
ADMET 2016 will provide a series of practical case studies, interactive roundtables and panel discussions facilitated by leading industry experts that will provide executives with useful tools and best practices to:
2016 Speaker Line up:
CHAIRMAN:
Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
KEYNOTE SPEAKERS:
Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
Kunal Taskar, Senior Investigator, DMPK, GSK
Karelle Menochet, Principal Scientist DMPK, UCB Pharma
Laurent Salphati, Senior Scientist, Genentech
Carl Petersson, DMPK NCE Senior Designer, Merck Serono
Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck
How to register:
EARLY BIRD offers available
Visit the event website www.admet-event.com/rsc or contact Matthew Apps on 02078276093 or mapps@smi-online.co.uk
13 – 14 June 2016
London, UK
Contact e-mail: zgale@smi-online.co.uk
Contact tel: +44 (0) 207 827 6093
www.admet-event.com/rsc
The SMi Group is proud to announce the return of the 11th annual ADMET conference taking place in London on the 13th – 14th June.
This event will explore novel and emerging non-clinical ADME approaches, structure based prediction of ADME properties, PK/PD modelling to validate drug targets, toxicity and much more.
ADMET 2016 will provide a series of practical case studies, interactive roundtables and panel discussions facilitated by leading industry experts that will provide executives with useful tools and best practices to:
- Discover application of PBPK to drug development in rare diseases
- Review the role of drug transporters in drug delivery to CNS diseases
- Learn about better models for understanding, predicting and avoiding drug induced liver injury
- Discuss in silico approaches to evidence-based mechanistic modelling
- Analyse early dose predictions – a valuable tool in risk assessment and optimisation of small molecules
2016 Speaker Line up:
CHAIRMAN:
Thierry Lave, Head DMPK Discovery and Development Project Leaders (CNS/CVM), Roche
KEYNOTE SPEAKERS:
Friedemann Schmidt, R&D DSAR Preclinical Safety, Sanofi-Aventis
Kunal Taskar, Senior Investigator, DMPK, GSK
Karelle Menochet, Principal Scientist DMPK, UCB Pharma
Laurent Salphati, Senior Scientist, Genentech
Carl Petersson, DMPK NCE Senior Designer, Merck Serono
Lena Gustavsson, Head of Sections Drug-Drug Interactions, Lundbeck
How to register:
EARLY BIRD offers available
Visit the event website www.admet-event.com/rsc or contact Matthew Apps on 02078276093 or mapps@smi-online.co.uk
